Alaa Othman

About

Alaa Othman is the Head of the Metabolomics Unit at ETH Zurich, Switzerland. His research focuses on metabolomics, with recent articles examining non-invasive biomarker candidates for health monitoring, mitochondrial and muscle dysfunction, and the impact of cholesterol trafficking on microglial morphology. He is also investigating the neurological consequences of diabetes and the effects of cell-derived nanovesicles in therapeutic applications for chronic liver disease.